Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Microbiology

Vol 9 No 1 (2024): June

Lactobacillus, Bifidobacterium and Streptococcus, Probiotic Bacteria Supplements, Induce DNA Repair of Local Breast Cancer Cell Line AMJ13
Lactobacillus, Bifidobacterium dan Streptococcus, Suplemen Bakteri Probiotik, Menginduksi Perbaikan DNA pada Garis Sel Kanker Payudara Lokal AMJ13



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.10286
Published
June 30, 2024

Abstract

General Background: Breast cancer is the most prevalent cancer affecting women, with increasing incidence worldwide. Specific Background: Recent research has focused on the role of epigenetic changes in DNA damage, repair mechanisms, and the potential therapeutic effects of probiotics. Probiotics have shown promise in promoting tissue regeneration and DNA repair. Knowledge Gap: However, the precise impact of probiotics on DNA repair in cancer cells, specifically breast cancer cells, remains underexplored. Aims: This study aimed to evaluate the effects of probiotics on DNA damage repair in AMJ13 Iraqi breast cancer cells and assess the cytotoxic effects of probiotics on these cells. Results: Using the comet assay, we found significant increases in DNA damage repair in AMJ13 cells treated with Lactobacillus plantarum (T1) and a combination of eight probiotic strains (T2). Exposure to T1 for 48 hours resulted in significant increases in tail DNA (P≤0.001), head DNA (P≤0.001), and tail moment (P<0.001), while T2 showed similar significant increases at 72 hours (P<0.05). Image analysis further supported the DNA repair potential of probiotics, as indicated by a small tail curve for treated cells. Novelty: This study provides novel insights into the therapeutic potential of probiotics in breast cancer treatment by demonstrating their capacity to enhance DNA repair mechanisms in cancer cells. Implications: The findings suggest that probiotic therapy may be a promising adjunct treatment in breast cancer, offering a new avenue for cancer management through the enhancement of DNA repair and reduction of DNA damage.

Highlights:

 

  1. Probiotics significantly repaired DNA damage in breast cancer cells.
  2. T1 and T2 enhanced DNA repair within 48-72 hours.
  3. Probiotics offer potential as breast cancer adjunct therapy.

 

Keywords: Breast cancer, probiotics, DNA repair, AMJ13 cells, cytotoxicity

References

  1. . S. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray, "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries," CA Cancer J. Clin., vol. 71, pp. 209–249, 2021, doi: 10.3322/caac.21660.
  2. . Iraqi Cancer Board, Results of the Iraqi Cancer Registry 2009. Baghdad, Iraq: Iraqi Cancer Registry Center, Ministry of Health, 2010.
  3. . S. L. Pandrangi, S. A. R. Bagadi, N. K. Sinha, et al., "Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis," Cancer Cell Int., vol. 14, no. 1, p. 14, 2014.
  4. . A. M. Al-Shammari, M. A. Alshami, M. A. Umran, A. A. Almukhtar, N. Y. Yaseen, K. Raad, and A. A. Hussien, "Establishment and characterization of a receptor-negative, hormone-nonresponsive breast cancer cell line from an Iraqi patient," Breast Cancer: Targets and Therapy, pp. 223-230, 2015.
  5. . L. Zhong, X. Zhang, and M. Covasa, "Emerging roles of lactic acid bacteria in protection against colorectal cancer," World J. Gastroenterol., vol. 20, pp. 7878–7886, 2014.
  6. . K. Lu, S. Dong, X. Wu, R. Jin, and H. Chen, "Probiotics in cancer," Front. Oncol., vol. 11, p. 638148, 2021.
  7. . M. Rodriguez-Arrastia, A. Martinez-Ortigosa, L. Rueda-Ruzafa, A. F. Ayora, C. Ropero-Padilla, "Probiotic supplements on oncology patients’ treatment-related side effects: A systematic review of randomized controlled trials," Int. J. Environ. Res. Public Health, vol. 18, p. 4265, 2021, doi: 10.3390/ijerph18084265.
  8. . T. L. Bedada, T. K. Feto, K. S. Awoke, A. D. Garedew, F. T. Yifat, and D. J. Birri, "Probiotics for cancer alternative prevention and treatment," Biomed. Pharmacother., vol. 129, p. 110409, 2020.
  9. . H. S. El-Nezami, N. N. Polychronaki, J. Ma, H. Zhu, W. Ling, E. K. Salminen, R. O. Juvonen, S. J. Salminen, T. Poussa, and H. M. Mykkänen, "Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China," Am. J. Clin. Nutr., vol. 83, pp. 1199–1203, 2006.
  10. . L. Mendoza, "Potential effect of probiotics in the treatment of breast cancer," Oncol. Rev., vol. 13, p. 422, 2019.
  11. . K. Hirayama and J. Rafter, "The role of probiotic bacteria in cancer prevention," Microbes Infect., vol. 2, no. 6, pp. 681-686, 2000.
  12. . P. I. Kim, M. Y. Jung, Y. H. Chang, S. Kim, S. J. Kim, and Y. H. Park, "Probiotic properties of Lactobacillus and Bifidobacterium strains isolated from porcine gastrointestinal tract," Appl. Microbiol. Biotechnol., vol. 74, pp. 1103-1111, 2007.
  13. . M. Khaledi, H. E. Gouvarchin Ghaleh, M. A. Abyazi, H. M. Hosseini, and R. Golmohammadi, "The anticancer properties of probiotic species," J. Appl. Biotechnol. Reports, vol. 10, no. 4, pp. 1123-1139, 2023.
  14. . M. Kumar, A. Kumar, R. Nagpal, D. Mohania, P. Behare, V. Verma, P. Kumar, D. Poddar, P. K. Aggarwal, C. J. K. Henry, and S. Jain, "Cancer-preventing attributes of probiotics: an update," Int. J. Food Sci. Nutr., vol. 61, no. 5, pp. 473-496, 2010.
  15. . L. S. A. Al-Abdulwahid, "Modulation of macrophage and epithelial cell immune defences by probiotic bacteria: immune stimulation versus suppression," Ph.D. dissertation, Sch. Plymouth Univ., Plymouth, UK, 2021.
  16. . N. Habil, "Probiotic modulation of mucosal immune responses in an in vitro co-culture model," Ph.D. dissertation, Sch. Plymouth Univ., Plymouth, UK, 2013.
  17. . A. Mercenier, H. Müller-Alouf, and C. Grangette, "Lactic acid bacteria as live vaccines," Curr. Issues Mol. Biol., vol. 2, no. 1, pp. 17-25, 2000.
  18. . R. Docampo, S. N. Moreno, and F. S. Cruz, "Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate," Mol. Biochem. Parasitol., vol. 27, no. 2-3, pp. 241-247, 1988.
  19. . N. P. Singh, M. T. McCoy, R. R. Tice, and E. L. Schneider, "A simple technique for quantitation of low levels of DNA damage in individual cells," Exp. Cell Res., vol. 175, no. 1, pp. 184-191, 1988.
  20. . Z. Saad, "Determination of DNA damage induced after bitter orange (Citrus aurantium) essential oil administrated in vivo," Iraqi J. Cancer Med. Genet., vol. 9, no. 2, 2016.
  21. . K. S. Prabhu, H. Q. Sadida, S. Kuttikrishnan, K. Junejo, A. A. Bhat, and S. Uddin, "Beyond genetics: Exploring the role of epigenetic alterations in breast cancer," Pathol. Res. Pract., p. 155174, 2024.
  22. . M. Arnold, E. Morgan, H. Rumgay, A. Mafra, D. Singh, M. Laversanne, J. Vignat, J. R. Gralow, F. Cardoso, S. Siesling, and I. Soerjomataram, "Current and future burden of breast cancer: Global statistics for 2020 and 2040," The Breast, vol. 66, pp. 15-23, 2022.
  23. . A. Tiptiri-Kourpeti, K. Spyridopoulou, V. Santarmaki, G. Aindelis, E. Tompoulidou, E. E. Lamprianidou, G. Saxami, P. Ypsilantis, E. S. Lampri, C. Simopoulos, and I. Kotsianidis, "Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells," PLoS One, vol. 11, no. 2, p. e0147960, 2016.
  24. . N. Chobdar and C. Ahmadizadeh, "The effect of Lactobacillus brevis on apoptosis and casp (casp8, casp3) gene expression in HeLa cancer cells," Iran J. Med. Microbiol., vol. 14, pp. 84–100, 2020.
  25. . H. LeBlanc, D. Lawrence, E. Varfolomeev, K. Totpal, J. Morlan, P. Schow, et al., "Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax," Nat. Med., vol. 8, pp. 274–281, 2002.
  26. . M. Abbas Ahmadi, M. Tajabadi Ebrahimi, S. Mehrabian, F. Tafvizi, H. Bahrami, and M. Dameshghian, "Antimutagenic and anticancer effects of lactic acid bacteria isolated from Tarhana through Ames test and phylogenetic analysis by 16S rDNA," Nutr. Cancer, vol. 66, no. 8, pp. 1406-1413, 2014.
  27. . A. Parisa, G. Roya, R. Mahdi, R. Shabnam, E. Maryam, and T. Malihe, "Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis," PLoS One, vol. 15, no. 5, p. e0232930, 2020.
  28. . N. Sehrawat, M. Yadav, M. Singh, V. Kumar, V. R. Sharma, and A. K. Sharma, "Probiotics in microbiome ecological balance providing a therapeutic window against cancer," Semin. Cancer Biol., vol. 70, pp. 24-36, 2021.
  29. . V. Mishra, C. Shah, N. Mokashe, R. Chavan, H. Yadav, and J. Prajapati, "Probiotics as potential antioxidants: a systematic review," J. Agric. Food Chem., vol. 63, no. 14, pp. 3615-3626, 2015.
  30. . M. Dolati, F. Tafvizi, M. Salehipour, T. K. Movahed, and P. Jafari, "Inhibitory effects of probiotic Bacillus coagulans against MCF7 breast cancer cells," Iran J. Microbiol., vol. 13, no. 6, p. 839, 2021.
  31. . R. Huang and P. K. Zhou, "DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy," Signal Transduct. Target. Ther., vol. 6, no. 1, p. 254, 2021.
  32. . J. Lukic, V. Chen, I. Strahinic, J. Begovic, H. Lev-Tov, S. C. Davis, M. Tomic-Canic, and I. Pastar, "Probiotics or pro-healers: the role of beneficial bacteria in tissue repair," Wound Repair Regen., vol. 25, no. 6, pp. 912-922, 2017.
  33. . J. N. Bernard, V. Chinnaiyan, J. Almeda, A. Catala-Valentin, and C. D. Andl, "Lactobacillus sp. facilitate the repair of DNA damage caused by bile-induced reactive oxygen species in experimental models of gastroesophageal reflux disease," Antioxidants, vol. 12, no. 7, p. 1314, 2023.
  34. . R. Scully, A. Panday, R. Elango, and N. A. Willis, "DNA double-strand break repair-pathway choice in somatic mammalian cells," Nat. Rev. Mol. Cell Biol., vol. 20, no. 11, pp. 698-714, 2019.
  35. . A. Shibata, "Regulation of repair pathway choice at two-ended DNA double-strand breaks," Mutat. Res./Fundam. Mol. Mech. Mutagen., vol. 803, pp. 51-55, 2017.
  36. . P. Huertas, "DNA resection in eukaryotes: deciding how to fix the break," Nat. Struct. Mol. Biol., vol. 17, no. 1, pp. 11-16, 2010.
  37. . R. D. Johnson and M. Jasin, "Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells," EMBO J., vol. 19, no. 13, pp. 3398-3407, 2000.
  38. . L. Dominici, M. Villarini, F. Trotta, E. Federici, G. Cenci, and M. Moretti, "Protective effects of probiotic Lactobacillus rhamnosus IMC501 in mice treated with PhIP," J. Microbiol. Biotechnol., vol. 24, no. 3, pp. 371-378, 2014.
  39. . A. Górska, D. Przystupski, M. J. Niemczura, and J. Kulbacka, "Probiotic bacteria: a promising tool in cancer prevention and therapy," Curr. Microbiol., vol. 76, pp. 939-949, 2019.

Downloads

Download data is not yet available.